All-atom universal binder generation (BoltzGen)
Практический сценарий
Frontier all-atom binder design across proteins, peptides, nanobodies. Preprint.
Вход
- target biomolecule
- design specification
Pipeline diagram
All-atom generation
→Integrated ranking
→Independent prediction + assays
Mermaid diagram
flowchart TD
A[Target + design spec] --> B[BoltzGen all-atom diffusion]
B --> C[Integrated folding/ranking]
C --> D[Independent validation]
D --> E[Experimental assays]Стадии pipeline
| Стадия | Архитектурный класс | Что происходит | Генерация или оценка | Generator | Промежуточный объект | Альтернативы |
|---|---|---|---|---|---|---|
| All-atom generation | All-atom diffusion unified with folding | Генерируется binder sequence–structure | generation | boltzgen | Binder complexes | BindCraft, RFantibody |
| Integrated ranking | Unified folding/ranking | In-model ranking | evaluation | NR | Ranked designs | NR |
| Independent prediction + assays | External | Обязательная независимая проверка | external_evaluation | NR | Hits | NR |
Hardware и runtime
NR. MIT code + weights, but preprint.
Evidence level
3–4 prospective claimed in preprint; evidence differs by modality. Not full IgG evidence.
Точки отказа
- Treat preprint as peer-reviewed.
- Assume IgG evidence from nanobody examples.
- Unified scores as independent validation.
Критерии решения
- Accept preprint risk?
- Need nanobody vs miniprotein vs peptide?